Gaush Meditech IPOs on Hong Kong Stock Exchange at HKD 21.4 per Share
China-based Gaush Meditech Ltd reportedly made an initial public offering (IPO) at the Hong Kong...
Northeast Pharmaceutical Fined RMB 133M for Monopoly Selling
Northeast Pharmaceutical Co., Ltd (SHE: 000597) was fined RMB 133 million (USD 19m) by the...
Dizal Pharma Presents Golidocitinib Data at ASH Annual Meeting
China-based Dizal Pharmaceutical Co., Ltd (SHA: 688192) presented the latest clinical data on golidocitinib (DZD4205)...
HitGen and Nitrase Therapeutics Enter Research Agreement
China-based HitGen Inc. (SHA: 688222) announced a research agreement with US firm Nitrase Therapeutics, Inc....
Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research
Sequanta Technologies, a multi-omics research and clinical service provider based in Shanghai, and Iomics Biosciences...
Innoforce Partners with RNAimmune for mRNA Development and Production
Hangzhou-based biopharma partner company Innoforce Pharmaceuticals Co., Ltd struck a partnership with RNAimmune, a spin-off...
NMPA Approves COVID-19 Antigen Detection Reagents from Four Companies
The National Medical Products Administration (NMPA) announced the marketing approvals for COVID-19 antigen detection reagents...
Biozon Partners with Agilent Technologies to Boost ICP-MS in China Clinics
Zhejiang-based third-party detection service company Biozon struck a partnership with US firm Agilent Technologies. The...
Sino Biopharmaceutical’s ATR Kinase Inhibitor TCC1727 Accepted for FDA Review
China-based Sino Biopharmaceutical Ltd (HKG: 1177) announced the acceptance for review of its Investigational New...
Acotec Scientific and Boston Scientific Enter Acquisition and Collaboration Agreement
China-based Acotec Scientific Holdings Ltd (HKG: 6669) and US major Boston Scientific Corporation (NYSE: BSX)...
Biogen’s Aducanumab Administered to Chinese Patient for First Time
US major Biogen’s (NASDAQ: BIIB) Alzheimer’s disease (AD) therapy aducanumab has been administered to a...
Stemirna Therapeutics’ COVID-19 mRNA Vaccine Gets EUA in Laos
Stemirna Therapeutics Co., Ltd, an mRNA drug developer based in Shanghai, has obtained Emergency Use...
Medbanks Set for IPO on Hong Kong Stock Exchange
Sipai Health Technology Co., Ltd, also known as Medbanks, is set to make an initial...
Fujian Cosunter Completes Enrollment for Phase I Study of GST-HG171
China-based Fujian Cosunter Pharmaceutical Co., Ltd (SHE: 300436) announced the completion of the enrollment of...
Alphamab Oncology Updates Clinical Studies for KN046 and KN026 at SABCS 2022
China-based Alphamab Oncology (HKG: 9966) updated the clinical studies for its KN046 and KN026 at...
Roche and Zhongshan Hospital Collaborate on Clinical Studies and Innovation Center
Swiss giant Roche’s (SWX: ROG) China unit and Roche Diagnostics’ China unit entered into a...
ASH 2022: China Biotechs Showcase Latest Clinical Trial Results
The American Society of Hematology (ASH) 2022 annual meeting, held online and offline in New...
Merck Partners with Tsinghua Shenzhen for Organoid 3D Printing System
Germany giant Merck (NYSE: MRK) struck a three-year partnership with Tsinghua Shenzhen International Graduate School,...
Luye Pharma Group Hands Over Seroquel Distribution Rights to DCH Auriga in Singapore
China-based Luye Pharma Group announced that it is handing Singapore distribution and marketing rights to...
RemeGen’s RC118 Receives Orphan Drug Designations for Gastric and Pancreatic Cancers
China-based RemeGen Ltd announced that its antibody drug conjugate (ADC) drug candidate RC118 has obtained...